{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:46:35Z","timestamp":1790930795461,"version":"4.1.0"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Autoimmune Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Autoimmune hepatitis (AIH) is a chronic necroinflammatory disease of the liver characterized by hypergammaglobulinemia, characteristic autoantibodies, association with HLA DR3 or DR4 and a favorable response to immunosuppressive treatment. The etiology is unknown. The detection of non-organ and liver-related autoantibodies remains the hallmark for the diagnosis of the disease in the absence of viral, metabolic, genetic, and toxic etiology of chronic hepatitis or hepatic injury. The current classification of AIH and the several autoantibodies\/target-autoantigens found in this disease are reported. Current aspects on the significance of these markers in the differential diagnosis and the study of pathogenesis of AIH are also stated. AIH is subdivided into two major types; AIH type 1 (AIH-1) and type 2 (AIH-2). AIH-1 is characterized by the detection of smooth muscle autoantibodies (SMA) and\/or antinuclear antibodies (ANA). Determination of antineutrophil cytoplasmic autoantibodies (ANCA), antibodies against the asialoglycoprotein receptor (anti-ASGP-R) and antibodies against to soluble liver antigens or liver-pancreas (anti-SLA\/LP) may be useful for the identification of patients who are seronegative for ANA\/SMA. AIH-2 is characterized by the presence of specific autoantibodies against liver and kidney microsomal antigens (anti-LKM type 1 or infrequently anti-LKM type 3) and\/or autoantibodies against liver cytosol 1 antigen (anti-LC1). Anti-LKM-1 and anti-LKM-3 autoantibodies are also detected in some patients with chronic hepatitis C (HCV) and chronic hepatitis D (HDV). Cytochrome P450 2D6 (CYP2D6) has been documented as the major target-autoantigen of anti-LKM-1 autoantibodies in both AIH-2 and HCV infection. Recent convincing data demonstrated the expression of CYP2D6 on the surface of hepatocytes suggesting a pathogenetic role of anti-LKM-1 autoantibodies for the liver damage. Family 1 of UDP-glycuronosyltransferases has been identified as the target-autoantigen of anti-LKM-3. For these reasons the distinction between AIH and chronic viral hepatitis (especially of HCV) is of particular importance. Recently, the molecular target of anti-SLA\/LP and anti-LC1 autoantibodies were identified as a 50 kDa UGA-suppressor tRNA-associated protein and a liver specific enzyme, the formiminotransferase cyclodeaminase, respectively. Anti-ASGP-R and anti-LC1 autoantibodies appear to correlate closely with disease severity and response to treatment suggesting a pathogenetic role of these autoantibodies for the hepatocellular injury. In general however, autoantibodies should not be used to monitor treatment, predict AIH activity or outcome. Finally, the current aspects on a specific form of AIH that may develop in some patients with a rare genetic syndrome, the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED) are also given. Autoantibodies against liver microsomes (anti-LM) are the specific autoantibodies detected in AIH as a disease component of APECED but also in cases of dihydralazine-induced hepatitis. Cytochrome P450 1A2 has been identified as the target-autoantigen of anti-LM autoantibodies in both APECED-related AIH and dihydralazine-induced hepatitis. The latter may indicate that similar autoimmune pathogenetic mechanisms can lead to liver injury in susceptible individuals irrespective of the primary defect. Characterization of the autoantigen-autoantibody repertoire continues to be an attractive and important tool to get access to the correct diagnosis and to gain insight into the as yet unresolved mystery of how hepatic tolerance is given up and AIH ensues.<\/jats:p>","DOI":"10.1186\/1740-2557-1-2","type":"journal-article","created":{"date-parts":[[2004,10,21]],"date-time":"2004-10-21T06:24:15Z","timestamp":1098339855000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":112,"title":["Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease"],"prefix":"10.1186","volume":"1","author":[{"given":"Kalliopi","family":"Zachou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Rigopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George N","family":"Dalekos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,10,15]]},"reference":[{"key":"1_CR1","first-page":"4517","volume":"118","author":"JE Berdal","year":"1998","unstructured":"Berdal JE, Ebbesen J, Rydning A: Incidence and prevalence of autoimmune liver diseases. Tidsskr Nor Laegeforen. 1998, 118: 4517-4519.","journal-title":"Tidsskr Nor Laegeforen"},{"key":"1_CR2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","volume":"33","author":"KM Boberg","year":"1998","unstructured":"Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H: Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol. 1998, 33: 99-103.","journal-title":"Scand J Gastroenterol"},{"key":"1_CR3","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/gast.2001.24227","volume":"120","author":"MP Manns","year":"2001","unstructured":"Manns MP, Strassburg CP: Autoimmune hepatitis: clinical challenges. Gastroenterology. 2001, 120: 1502-1517.","journal-title":"Gastroenterology"},{"key":"1_CR4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/00003495-199957010-00005","volume":"57","author":"AJ Czaja","year":"1999","unstructured":"Czaja AJ: Drug therapy in the management of type 1 autoimmune hepatitis. Drugs. 1999, 57: 49-68.","journal-title":"Drugs"},{"issue":"Suppl 1","key":"1_CR5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0168-8278(00)80425-0","volume":"32","author":"P Obermayer-Straub","year":"2000","unstructured":"Obermayer-Straub P, Strassburg CP, Manns MP: Autoimmune hepatitis. J Hepatol. 2000, 32 (Suppl 1): 181-197.","journal-title":"J Hepatol"},{"key":"1_CR6","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WGE, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston ALWF, Fainboim L, Heathcote J, Homberg JC, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RNM, Maddrey WC, Manns MP, McFarlane IG, Meyer zum B\u00fcschenfelde K-H, Mieli-Vergani G, Nakanuma Y, Nishioka M, Penner E, Porta G, Portmann BC, Reed DW, Rodes J, Schalm SW, Scheuer PJ, Schrumpf E, Seki T, Toda G, Tsuji T, Tygstrup N, Vergani D, Zeniya M: International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999, 31: 929-938.","journal-title":"J Hepatol"},{"key":"1_CR7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3810\/pgm.1998.08.563","volume":"104","author":"EL Krawitt","year":"1998","unstructured":"Krawitt EL: Can you recognize autoimmune hepatitis?. Postgrad Med. 1998, 104: 145-149. and 152","journal-title":"Postgrad Med"},{"key":"1_CR8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1055\/s-2002-35702","volume":"22","author":"IG McFarlane","year":"2002","unstructured":"McFarlane IG: Definition and classification of autoimmune hepatitis. Semin Liver Dis. 2002, 22: 317-324.","journal-title":"Semin Liver Dis"},{"key":"1_CR9","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0168-8278(97)80453-9","volume":"26","author":"G Toda","year":"1997","unstructured":"Toda G, Zeniya M, Watanabe F, Imawari M, Kiyosawa K, Nishioka M, Tsuji T, Omata M: Present status of autoimmune hepatitis in Japan-correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune hepatitis. J Hepatol. 1997, 26: 1207-1212.","journal-title":"J Hepatol"},{"key":"1_CR10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/qjmed\/90.4.289","volume":"90","author":"DR Parker","year":"1997","unstructured":"Parker DR, Kingham JGC: Type I autoimmune hepatitis is primarily a disease of later life. Q J Med. 1997, 90: 289-296.","journal-title":"Q J Med"},{"key":"1_CR11","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1572-0241.2001.03782.x","volume":"96","author":"C Schramm","year":"2001","unstructured":"Schramm C, Kanzler S, Buschenfelde KH, Galle PR, Lohse AW: Autoimmune hepatitis in the elderly. Am J Gastroenterol. 2001, 96: 1587-1591.","journal-title":"Am J Gastroenterol"},{"key":"1_CR12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s005350050247","volume":"34","author":"K Omagari","year":"1999","unstructured":"Omagari K, Kinoshita H, Kato Y, Nakata K, Kanematsu T, Kusumoto Y, Mori I, Furukawa R, Tanioka H, Tajima H, Koga M, Yano M, Kohno S: Clinical features of 89 patients with autoimmune hepatitis in Nagasaki Prefecture, Japan. J Gastroenterol. 1999, 34: 221-226.","journal-title":"J Gastroenterol"},{"key":"1_CR13","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","volume":"18","author":"PJ Johnson","year":"1993","unstructured":"Johnson PJ, McFarlane IG: Meeting report of the International Autoimmune Hepatitis Group. Hepatology. 1993, 18: 998-1005.","journal-title":"Hepatology"},{"key":"1_CR14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0953-6205(02)00089-4","volume":"13","author":"GN Dalekos","year":"2002","unstructured":"Dalekos GN, Zachou K, Liaskos C, Gatselis N: Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview. Eur J Intern Med. 2002, 13: 293-303.","journal-title":"Eur J Intern Med"},{"key":"1_CR15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2002-35704","volume":"22","author":"CP Strassburg","year":"2002","unstructured":"Strassburg CP, Manns MP: Autoantibodies and autoantigens in autoimmune hepatitis. Semin Liver Dis. 2002, 22: 339-351.","journal-title":"Semin Liver Dis"},{"key":"1_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1568-9972(03)00051-X","volume":"3","author":"N Fabien","year":"2004","unstructured":"Fabien N, Desbos A, Bienvenu J, Magdalou J: Autoantibodies directed against the UDP-glucuronotransferases in human autoimmune hepatitis. Autoimmun Rev. 2004, 3: 1-9.","journal-title":"Autoimmun Rev"},{"key":"1_CR17","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","volume":"19","author":"V Desmet","year":"1994","unstructured":"Desmet V, Gerber MA, Hoofnagle JH, Manns M, Scheuer P: Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology. 1994, 19: 1513-1520.","journal-title":"Hepatology"},{"key":"1_CR18","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.1840070626","volume":"7","author":"JC Homberg","year":"1987","unstructured":"Homberg JC, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil SH, Poupon R, Darnis F, Levy VG, Grippon P: Chronic active hepatitis associated with anti-liver kidney microsome antibody type I: A second type of \"autoimmune hepatitis\". Hepatology. 1987, 7: 1333-1339.","journal-title":"Hepatology"},{"key":"1_CR19","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hep.1840080632","volume":"8","author":"E Martini","year":"1988","unstructured":"Martini E, Abuaf N, Cavalli F, Durand V, Johanet C, Homberg JC: Antibody to liver cytosol (anti-LC1) in patients with autoimmune hepatitis type 2. Hepatology. 1988, 8: 1662-1666.","journal-title":"Hepatology"},{"key":"1_CR20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(87)92024-1","volume":"i","author":"M Manns","year":"1987","unstructured":"Manns M, Gerken G, Kyriatsoulis A, Staritz M, Meyer zum B\u00fcschenfelde K-H: Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against soluble liver antigen. Lancet. 1987, i: 292-294.","journal-title":"Lancet"},{"key":"1_CR21","first-page":"921","volume":"87","author":"PA Berg","year":"1981","unstructured":"Berg PA, Stechemesser E, Strenz J: Hypergammaglobulinamische chronisch aktive Hepatitis mit Nachweis von Leber-Pancreas-spezifischen koplementbindenden Antikorpen. Verch Dtsch Ges Inn Med. 1981, 87: 921-927.","journal-title":"Verch Dtsch Ges Inn Med"},{"key":"1_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840180102","volume":"18","author":"E Stechemesser","year":"1993","unstructured":"Stechemesser E, Klein R, Berg PA: Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis. Hepatology. 1993, 18: 1-9.","journal-title":"Hepatology"},{"key":"1_CR23","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1053\/gast.2001.27103","volume":"121","author":"P Obermayer-Straub","year":"2001","unstructured":"Obermayer-Straub P, Perheentupa J, Braun S, Kayser A, Barut A, Loges S, Harms A, Dalekos G, Strassburg C, Manns MP: Hepatic autoantigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Gastroenterology. 2001, 121: 668-677.","journal-title":"Gastroenterology"},{"key":"1_CR24","first-page":"1353","volume":"82","author":"MG Clemente","year":"1997","unstructured":"Clemente MG, Obermayer-Straub P, Meloni A, Strassburg CP, Arangino V, Tukey RH, De Virgiliis S, Manns MP: Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab. 1997, 82: 1353-1361.","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR25","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0016-5085(98)70484-6","volume":"114","author":"MG Clemente","year":"1998","unstructured":"Clemente MG, Meloni A, Obermayer-Straub P, Frau F, Manns MP, De Virgiliis S: Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1. Gastroenterology. 1998, 114: 324-328.","journal-title":"Gastroenterology"},{"key":"1_CR26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng1297-399","volume":"17","author":"The Finish-German APECED Consortium","year":"1997","unstructured":"The Finish-German APECED Consortium: An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet. 1997, 17: 399-403.","journal-title":"Nat Genet"},{"key":"1_CR27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ng1297-393","volume":"17","author":"K Nagamine","year":"1997","unstructured":"Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, Krohn KJ, Lalioti MD, Mullis PE, Antonarakis SE, Kawasaki K, Asakawa S, Ito F, Shimizu N: Positional cloning of the APECED gene. Nat Genet. 1997, 17: 393-398.","journal-title":"Nat Genet"},{"key":"1_CR28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-2007-979814","volume":"28","author":"J Perheentupa","year":"1996","unstructured":"Perheentupa J: Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). Horm Metab Res. 1996, 28: 353-356.","journal-title":"Horm Metab Res"},{"key":"1_CR29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1385\/CRIAI:18:2:167","volume":"18","author":"P Obermayer-Straub","year":"2000","unstructured":"Obermayer-Straub P, Strassburg CP, Manns MP: Autoimmune polyglandular syndrome type 1. Clin Rev Allergy Immunol. 2000, 18: 167-183.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1_CR30","first-page":"1206","volume":"90","author":"AJ Czaja","year":"1995","unstructured":"Czaja AJ, Manns MP: The validity and importance of subtypes in autoimmune hepatitis: A point of view. Am J Gastroenterol. 1995, 90: 1206-1211.","journal-title":"Am J Gastroenterol"},{"key":"1_CR31","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0168-8278(99)80342-0","volume":"31","author":"S Kanzler","year":"1999","unstructured":"Kanzler S, Weidemann C, Gerken G, Lohr HF, Galle PR, Meyer zum Buschenfelde KH, Lohse AW: Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis. J Hepatol. 1999, 31: 635-640.","journal-title":"J Hepatol"},{"key":"1_CR32","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0168-8278(00)80361-X","volume":"33","author":"E Ballot","year":"2000","unstructured":"Ballot E, Homberg JC, Johanet C: Antibodies to soluble liver antigen: an additional marker in type 1 autoimmune hepatitis. J Hepatol. 2000, 33: 208-215.","journal-title":"J Hepatol"},{"key":"1_CR33","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","volume":"25","author":"GV Gregorio","year":"1997","unstructured":"Gregorio GV, Portman B, Reid F, Donaldson PT, Doherty DG, McCartney M, Mowat AP, Vergani D, Mieli-Vergani G: Autoimmune hepatitis in childhood: a 20 year experience. Hepatology. 1997, 25: 541-547.","journal-title":"Hepatology"},{"key":"1_CR34","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0168-8278(97)80106-7","volume":"26","author":"A Jurado","year":"1997","unstructured":"Jurado A, Cardaba B, Jara P, Cuadrado P, Hierro L, de Andres B, del Pozo V, Cortegano MI, Gallardo S, Camarena C, Barcena R, Castaner JL, Alvarez R, Lahoz C, Palomino P: Autoimmune hepatitis type 2 and hepatitis C virus infection: study of HLA antigens. J Hepatol. 1997, 26: 983-991.","journal-title":"J Hepatol"},{"key":"1_CR35","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0016-5085(94)90078-7","volume":"107","author":"AJ Czaja","year":"1994","unstructured":"Czaja AJ, Nishioka M, Morshed SA, Haciya T: Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis. Gastroenterology. 1994, 107: 200-207.","journal-title":"Gastroenterology"},{"key":"1_CR36","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0168-8278(99)80358-4","volume":"31","author":"CP Strassburg","year":"1999","unstructured":"Strassburg CP, Manns MP: Antinuclear antibody (ANA) patterns in hepatic and extrahepatic autoimmune disease. J Hepatol. 1999, 31: 751-","journal-title":"J Hepatol"},{"key":"1_CR37","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1023\/A:1018809431189","volume":"42","author":"AJ Czaja","year":"1997","unstructured":"Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB: Antinuclear antibodies and patterns of nuclear immunoflorescence in type 1 autoimmune hepatitis. Dig Dis Sci. 1997, 42: 1688-1696.","journal-title":"Dig Dis Sci"},{"key":"1_CR38","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0168-8278(96)80290-X","volume":"25","author":"C Strassburg","year":"1996","unstructured":"Strassburg C, Alex B, Zindy F, Gerken G, Luttig B, Meyer zum Buschenfelde KH, Brechot C, Manns MP: Identification of Cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic diseases. J Hepatol. 1996, 25: 859-866.","journal-title":"J Hepatol"},{"key":"1_CR39","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.510260306","volume":"26","author":"AJ Czaja","year":"1997","unstructured":"Czaja AJ, Morshed SA, Parveen S, Nishioka M: Antibodies to single stranded and double-stranded DNA in antinuclear antibody-positive type 1 autoimmune hepatitis. Hepatology. 1997, 26: 567-572.","journal-title":"Hepatology"},{"key":"1_CR40","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1023\/A:1018880429469","volume":"43","author":"S Parveen","year":"1998","unstructured":"Parveen S, Morshed SA, Arima K, Nishioka M, Czaja AJ, Chow WC, Ng HS: Antibodies to Ro\/La, Cenp-B, and snRNPs antigens in autoimmune hepatitis of North America versus Asia: patterns of immunofluorescence, ELISA reactivities, and HLA association. Dig Dis Sci. 1998, 43: 1322-1331.","journal-title":"Dig Dis Sci"},{"key":"1_CR41","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/hep.510240515","volume":"24","author":"AJ Czaja","year":"1996","unstructured":"Czaja AJ, Cassani F, Cataleta M, Valenti P, Bianchi FB: Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology. 1996, 24: 1068-1073.","journal-title":"Hepatology"},{"key":"1_CR42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2362.1993.tb00765.x","volume":"23","author":"GN Dalekos","year":"1993","unstructured":"Dalekos GN, Manoussakis MN, Zervou E, Tsianos EV, Moutsopoulos HM: Immunologic and viral markers in anti-HIV negative heroin addicts. Eur J Clin Invest. 1993, 23: 219-225.","journal-title":"Eur J Clin Invest"},{"key":"1_CR43","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/hep.510260305","volume":"26","author":"F Cassani","year":"1997","unstructured":"Cassani F, Cataleta M, Valentini P, Muratori P, Giostra F, Francesconi R, Muratori L, Lenzi M, Bianchi G, Zauli D, Bianchi FB: Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on disease profile. Hepatology. 1997, 26: 561-566.","journal-title":"Hepatology"},{"key":"1_CR44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-128-5-199803010-00015","volume":"128","author":"GN Dalekos","year":"1998","unstructured":"Dalekos GN, Hatzis J, Tsianos EV: Dermatologic disease during interferon-alpha therapy for chronic viral hepatitis. Ann Intern Med. 1998, 128: 409-410.","journal-title":"Ann Intern Med"},{"key":"1_CR45","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00042737-200012010-00013","volume":"12","author":"GN Dalekos","year":"2000","unstructured":"Dalekos GN, Kistis K, Boumba D, Voulgari P, Zervou EK, Drosos AA, Tsianos EV: Increased incidence of anticardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to antiphospholipid syndrome. Eur J Gastroenterol Hepatol. 2000, 12: 67-74.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1_CR46","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/hep.510240309","volume":"24","author":"GV Gregorio","year":"1996","unstructured":"Gregorio GV, Jones H, Chouldhuri K, Vegnente A, Bortolotti F, Mieli-Vergani G, Vergani D: Autoantibody prevalence in chronic hepatitis B virus infection: effect of interferon alpha. Hepatology. 1996, 24: 308-312.","journal-title":"Hepatology"},{"key":"1_CR47","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0168-8278(99)80096-8","volume":"30","author":"AJ Czaja","year":"1999","unstructured":"Czaja AJ: Behaviour and significance of autoantibodies in type 1 autoimmune hepatitis. J Hepatol. 1999, 30: 394-401.","journal-title":"J Hepatol"},{"key":"1_CR48","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(85)91147-X","volume":"i","author":"FJ Van der Woude","year":"1985","unstructured":"Van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, van der Giessen M, van der Hem GK: Autoantibodies against neutrophils and monocytes tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet. 1985, i: 425-429.","journal-title":"Lancet"},{"key":"1_CR49","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM198806233182504","volume":"318","author":"RJ Falk","year":"1988","unstructured":"Falk RJ, Jennette JC: Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med. 1988, 318: 1651-1657.","journal-title":"N Engl J Med"},{"key":"1_CR50","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/gut.34.5.658","volume":"34","author":"GN Dalekos","year":"1993","unstructured":"Dalekos GN, Manoussakis MN, Goussia AC, Tsianos EV, Moutsopoulos HM: Soluble interleukin-2 receptors, antineutrophil cytoplasmic antibodies and other autoantibodies in patients with ulerative colitis. Gut. 1993, 34: 658-664.","journal-title":"Gut"},{"key":"1_CR51","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/0016-5085(91)70028-V","volume":"100","author":"RH Duerr","year":"1991","unstructured":"Duerr RH, Targan SR, Landers CJ, LaRusso NF, Lindsay KL, Wiesner RH, Shanahan F: Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 1991, 100: 1385-1391.","journal-title":"Gastroenterology"},{"key":"1_CR52","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1440-1746.1994.tb01214.x","volume":"9","author":"CS Pokorny","year":"1994","unstructured":"Pokorny CS, Norton ID, McCaughan GW, Selby WS: Anti-neutrophil cytoplasmic antibody: a prognostic indicator in primary sclerosing cholangitis. J Gastroenterol Hepatol. 1994, 9: 40-44.","journal-title":"J Gastroenterol Hepatol"},{"key":"1_CR53","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/0016-5085(95)90215-5","volume":"108","author":"SR Targan","year":"1995","unstructured":"Targan SR, Landers C, Vidrich A, Czaja AJ: High titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology. 1995, 108: 1159-1166.","journal-title":"Gastroenterology"},{"key":"1_CR54","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0168-8278(00)80241-X","volume":"32","author":"C Roozendaal","year":"2000","unstructured":"Roozendaal C, de Jong MA, van den Berg AP, van Wijk RT, Limburg PC, Kallenberg CGM: Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases. J Hepatol. 2000, 32: 734-741.","journal-title":"J Hepatol"},{"key":"1_CR55","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/hep.510280207","volume":"28","author":"B Terjung","year":"1998","unstructured":"Terjung B, Herzog V, Worman HJ, Gestmann I, Bauer C, Sauerbruch T, Spengler U: Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins. Hepatology. 1998, 28: 332-340.","journal-title":"Hepatology"},{"key":"1_CR56","first-page":"3034","volume":"46","author":"C Roozendaal","year":"1999","unstructured":"Roozendaal C, Kallenberg CGM: Anti-neutrophil cytoplasm autoantibodies (ANCA) in autoimmune liver diseases. Hepatogastroenterology. 1999, 46: 3034-3040.","journal-title":"Hepatogastroenterology"},{"key":"1_CR57","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.510250510","volume":"25","author":"D Zauli","year":"1997","unstructured":"Zauli D, Ghetti S, Grassi A, Descovich C, Cassani F, Ballardini G, Muratori L, Bianchi FB: Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis. Hepatology. 1997, 25: 1105-1107.","journal-title":"Hepatology"},{"key":"1_CR58","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1440-1746.2000.02078.x","volume":"15","author":"S Lindgren","year":"2000","unstructured":"Lindgren S, Nilsson S, Nassberger L, Verbaan H, Wieslander J: Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club. J Gastroenterol Hepatol. 2000, 15: 437-442.","journal-title":"J Gastroenterol Hepatol"},{"key":"1_CR59","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1600-0676.1996.tb00700.x","volume":"16","author":"C Claise","year":"1996","unstructured":"Claise C, Johanet C, Bouhnik Y, Kapel N, Homberg JC, Poupon R: Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases. Liver. 1996, 16: 1095-1100.","journal-title":"Liver"},{"key":"1_CR60","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0168-8278(05)80508-2","volume":"20","author":"GN Dalekos","year":"1994","unstructured":"Dalekos GN, Tsianos EV: Antineutrophil antibodies in chronic viral hepatitis. J Hepatol (Letter). 1994, 20: 561-","journal-title":"J Hepatol (Letter)"},{"key":"1_CR61","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2249.2002.01827.x","volume":"128","author":"Y-Y Wu","year":"2002","unstructured":"Wu Y-Y, Hsu T-C, Chen T-Y, Liu T-C, Liu G-Y, Lee Y-J, Tsay G-J: Proteinase 3 and dihydrolipoamide dehydrogenase (E3) are major autoantigens in hepatitis C virus (HCV) infection. Clin Exp Immunol. 2002, 128: 347-352.","journal-title":"Clin Exp Immunol"},{"key":"1_CR62","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/hep.1840170310","volume":"17","author":"AHL Mulder","year":"1993","unstructured":"Mulder AHL, Horst G, Haagsma EB, Limburg PC, Kleibeuker JH, Kallenberg GM: Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology. 1993, 17: 411-417.","journal-title":"Hepatology"},{"key":"1_CR63","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/gast.2001.20223","volume":"120","author":"AJ Czaja","year":"2001","unstructured":"Czaja AJ, Homburger HA: Autoantibodies in liver disease. Gastroenterolgy. 2001, 120: 239-249.","journal-title":"Gastroenterolgy"},{"key":"1_CR64","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/gut.44.6.867","volume":"44","author":"J Sobajima","year":"1999","unstructured":"Sobajima J, Ozaki S, Uesugi H, Osakada F, Inoue M, Fukuda Y, Shirakawa H, Yoshida M, Rokuhara A, Imai H, Kiyosawa K, Nakao K: High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis. Gut. 1999, 44: 867-873.","journal-title":"Gut"},{"key":"1_CR65","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0168-8278(97)80007-4","volume":"26","author":"T Orth","year":"1997","unstructured":"Orth T, Gerken G, Kellner R, Meyer zum B\u00fcschenfelde K-H, Mayet W-J: Actin is a target antigen of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune hepatitis type-1. J Hepatol. 1997, 26: 37-47.","journal-title":"J Hepatol"},{"key":"1_CR66","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0016-5085(94)90129-5","volume":"107","author":"U Treichel","year":"1994","unstructured":"Treichel U, McFarlane BM, Seki T, Krawitt EL, Alessi N, Stickel F, McFarlane IG, Kiyosawa K, Furuta S, Freni MA: Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis. Gastroenterology. 1994, 107: 799-804.","journal-title":"Gastroenterology"},{"key":"1_CR67","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/BF02088738","volume":"41","author":"AJ Czaja","year":"1996","unstructured":"Czaja AJ, Pfeifer KD, Decker RH, Vallari AS: Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis. Dig Dis Sci. 1996, 41: 1733-1740.","journal-title":"Dig Dis Sci"},{"key":"1_CR68","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/hep.1840110312","volume":"11","author":"BM McFarlane","year":"1990","unstructured":"McFarlane BM, Sipos J, Gove CD, McFarlane IG, Williams R: Antibodies against the hepatic asialoglycoprotein receptor perfused in situ preferentially attach to periportal liver cells in the rat. Hepatology. 1990, 11: 408-415.","journal-title":"Hepatology"},{"key":"1_CR69","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0753-3322(99)80096-1","volume":"53","author":"IG McFarlane","year":"1999","unstructured":"McFarlane IG: Pathogenesis of autoimmune hepatitis. Biomed Pharmacother. 1999, 53: 255-263.","journal-title":"Biomed Pharmacother"},{"key":"1_CR70","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0168-8278(05)80176-X","volume":"19","author":"U Treichel","year":"1993","unstructured":"Treichel U, Gerken G, Rossol S, Rotthauwe HW, Meyer zum Bunschenfelde K-H, Poralla AS: Autoantibodies against the human asialoglycoprotein receptor: effects of therapy in autoimmune and virus induced chronic active hepatitis. J Hepatol. 1993, 19: 55-63.","journal-title":"J Hepatol"},{"key":"1_CR71","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0168-8278(90)90119-C","volume":"11","author":"B Wachter","year":"1990","unstructured":"Wachter B, Kyriatsoulis A, Lohse AW, Gerken G, Meyer zum B\u00fcschenfelde KH, Manns M: Characterization of liver cytokeratin as a major target antigen of anti-SLA antibodies. J Hepatol. 1990, 11: 232-239.","journal-title":"J Hepatol"},{"key":"1_CR72","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-2008-1040438","volume":"11","author":"MP Manns","year":"1991","unstructured":"Manns MP: Cytoplasmic autoantigens in autoimmune hepatitis: Molecular analysis and clinical relevance. Sem Liver Dis. 1991, 11: 205-214.","journal-title":"Sem Liver Dis"},{"key":"1_CR73","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0168-8278(00)80375-X","volume":"33","author":"MP Manns","year":"2000","unstructured":"Manns MP: Antibodies to soluble liver antigen: specific marker of autoimmune hepatitis. J Hepatol. 2000, 33: 326-328.","journal-title":"J Hepatol"},{"key":"1_CR74","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0140-6736(00)02166-8","volume":"355","author":"I Wies","year":"2000","unstructured":"Wies I, Brunner S, Henninger J, Herkel J, Kanzler S, Meyer zum Buschenfelde KH, Lohse AW: Identification of target antigen for SLA\/LP autoantibodies in autoimmune hepatitis. Lancet. 2000, 355: 1510-1515.","journal-title":"Lancet"},{"key":"1_CR75","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0016-5085(98)70485-8","volume":"114","author":"J Wesierska-Gadek","year":"1998","unstructured":"Wesierska-Gadek J, Grimm R, Hitchman E, Penner E: Members of the glutathione S-transferase gene family are antigens in autoimmune hepatitis. Gastroenterology. 1998, 114: 329-335.","journal-title":"Gastroenterology"},{"key":"1_CR76","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/jhep.2001.22218","volume":"33","author":"M Volkmann","year":"2001","unstructured":"Volkmann M, Martin L, B\u00e4urle A, Heid H, Strassburg CP, Trautwein C, Fiehn W, Manns MP: Soluble liver antigen: isolation of a 35 kD recombinant protein (SLA-P35) specifically recognizing sera from patients with autoimmune hepatitis type 3. Hepatology. 2001, 33: 591-596.","journal-title":"Hepatology"},{"key":"1_CR77","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2249.2000.01280.x","volume":"121","author":"M Costa","year":"2000","unstructured":"Costa M, Rodriguez-Sanchez JL, Czaja AJ, Gelpi C: Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients with type-1 autoimmune hepatitis. Clin Exp Immunol. 2000, 121: 364-374.","journal-title":"Clin Exp Immunol"},{"key":"1_CR78","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1073\/pnas.89.20.9739","volume":"89","author":"C Gelpi","year":"1992","unstructured":"Gelpi C, Sontheimer E, Rodriguez-Sanchez J: Autoantibodies against a serine tRNA-protein complex implicated in cotranslational selenocysteine insertion. Proc Natl Acad Sci USA. 1992, 89: 9739-9743.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR79","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/gut.51.2.259","volume":"51","author":"M Baeres","year":"2002","unstructured":"Baeres M, Herkel J, Czaja AJ, Wies I, Kanzler S, Cancado EL, Porta G, Nishioka M, Simon T, Daehnrich C, Schlumberger W, Galle PR, Lohse AW: Establishment of standardised SLA\/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics. Gut. 2002, 51: 259-264.","journal-title":"Gut"},{"key":"1_CR80","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/jhep.2002.32092","volume":"36","author":"Y Ma","year":"2002","unstructured":"Ma Y, Okamoto M, Thomas MG, Bogdanos DP, Lopes AR, Portmann B, Underhill J, Durr R, Mieli-Vergani G, Vergani D: Antibodies to conformantional epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology. 2002, 36: 658-664.","journal-title":"Hepatology"},{"key":"1_CR81","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1365-2249.1997.4071302.x","volume":"108","author":"AM Yamamoto","year":"1997","unstructured":"Yamamoto AM, Johanet C, Duclos-Vallee J-C, Bustarret FA, Alvarez F, Homberg JC, Bach JF: A new approach to cytochrome CYP2D6 antibody detection in autoimmune hepatitis type-2 (AIH-2) and chronic hepatitis C virus (HCV) infection: a sensitive and quantitative radioligand assay. Clin Exp Immunol. 1997, 108: 396-400.","journal-title":"Clin Exp Immunol"},{"key":"1_CR82","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0168-8278(97)80477-1","volume":"26","author":"Y Ma","year":"1997","unstructured":"Ma Y, Gregorio G, Gaken J, Muratori L, Bianchi FB, Mieli-Vergani G, Vergani D: Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type-1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection. J Hepatol. 1997, 26: 1396-1402.","journal-title":"J Hepatol"},{"key":"1_CR83","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/0891693021000069556","volume":"35","author":"T Sugimura","year":"2002","unstructured":"Sugimura T, Obermayer-Straub P, Kayser A, Braun S, Loges S, Alex B, Luttig B, Johnson EF, Manns MP, Strassburg CP: A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450autoantigens. Autoimmunity. 2002, 35: 501-513.","journal-title":"Autoimmunity"},{"key":"1_CR84","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1572-0241.2002.05479.x","volume":"97","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ, Donaldson PT, Lohse AW: Antibodies to soluble liver antigen\/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis. Am J Gastroenterol. 2002, 97: 413-419.","journal-title":"Am J Gastroenterol"},{"key":"1_CR85","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1073\/pnas.84.2.551","volume":"84","author":"P Beaune","year":"1987","unstructured":"Beaune P, Dansette PM, Mansuy D, Kiffel L, Finck M, Amar C, Leroux JP, Homberg JC: Human antiendoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis directed against a human liver cytochrome P450 that hydroxylates the drug. Proc Natl Acad Sci USA. 1987, 84: 551-555.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR86","first-page":"331","volume":"15","author":"M Rizzetto","year":"1973","unstructured":"Rizzetto M, Swana G, Doniach D: Microsomal antibodies in active chronic hepatitis and other disorders. Clin Exp Immunol. 1973, 15: 331-344.","journal-title":"Clin Exp Immunol"},{"key":"1_CR87","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1172\/JCI113949","volume":"83","author":"M Manns","year":"1989","unstructured":"Manns M, Johnson EF, Griffin KJ, Tan EM, Sullivan KF: The major target antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450 db1. J Clin Invest. 1989, 83: 1066-1072.","journal-title":"J Clin Invest"},{"key":"1_CR88","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0006-291X(89)90027-2","volume":"159","author":"M Gueguen","year":"1989","unstructured":"Gueguen M, Yamamoto AM, Bernard O, Alvarez F: Anti-liver kidney microsome antibody type 1 recognizes cytochrome P450 db1. Biochem Biophys Res Commun. 1989, 159: 542-547.","journal-title":"Biochem Biophys Res Commun"},{"key":"1_CR89","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1073\/pnas.85.21.8256","volume":"85","author":"UM Zanger","year":"1988","unstructured":"Zanger UM, Hauri HP, Loeper J, Homberg JC, Meyer UA: Antibodies against human cytochrome P450 db 1 in autoimmune hepatitis type 2. Proc Natl Acad Sci USA. 1988, 85: 8256-8260.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR90","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/hep.1840120120","volume":"12","author":"M Manns","year":"1990","unstructured":"Manns M, Zanger U, Gerken G, Sullivan KF, Meyer zum Buschenfelde KH, Meyer UA, Eichelbaum M: Patients with type II autoimmune hepatitis express functionally intact cytochrome P450 db1 that is inhibited by LKM1 autoantibodies in vitro but not in vivo. Hepatology. 1990, 12: 127-132.","journal-title":"Hepatology"},{"key":"1_CR91","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI115443","volume":"88","author":"MP Manns","year":"1991","unstructured":"Manns MP, Griffin KJ, Sullivan KF, Johnson EF: LKM-1 autoantibodies recognize a short linear sequence in P450 2D6, a cytochrome P450 monooxygenase. J Clin Invest. 1991, 88: 1370-1378.","journal-title":"J Clin Invest"},{"key":"1_CR92","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/eji.1830230519","volume":"23","author":"AM Yamamoto","year":"1993","unstructured":"Yamamoto AM, Cresteil D, Boniface O, Clerc FF, Alvarez F: Identification and analysis of cytochrome P450 2D6 antigenic sites recognized by anti-liver kidney microsome type-1 antibodies (LKM1). Eur J Immunol. 1993, 23: 1105-1111.","journal-title":"Eur J Immunol"},{"key":"1_CR93","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1046\/j.1365-2249.1999.01027.x","volume":"118","author":"R Klein","year":"1999","unstructured":"Klein R, Zanger UM, Berg T, Hopf U, Berg PA: Overlapping but distinct specificities of anti-liver-kidney microsomes antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes. Clin Exp Immunol. 1999, 118: 290-297.","journal-title":"Clin Exp Immunol"},{"key":"1_CR94","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.4049\/jimmunol.170.3.1481","volume":"170","author":"N Kerkar","year":"2003","unstructured":"Kerkar N, Choudhuri K, Ma Y, Mahmoud A, Bogdanos DP, Muratori L, Bianchi F, Williams R, Mieli-Vergani G, Vergani D: Cytochrome P4502D6 (193\u2013212): a new immunodominant epitope and target of virus\/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol. 2003, 170: 1481-1489.","journal-title":"J Immunol"},{"key":"1_CR95","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0016-5085(95)90076-4","volume":"108","author":"JC Duclos-Valleye","year":"1995","unstructured":"Duclos-Valleye JC, Hajoui O, Yamamoto AM, Jacqz-Aigrain E, Alvarez F: Conformational epitopes on CYP2D6 are recognized by liver\/kidney microsomal antibodies. Gastroenterology. 1995, 108: 470-476.","journal-title":"Gastroenterology"},{"key":"1_CR96","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0168-8278(97)80107-9","volume":"26","author":"M Nishioka","year":"1997","unstructured":"Nishioka M, Morshed SA, Kono K, Himoto T, Parveen S, Arima K, Watanabe S, Manns MP: Frequency and significance of antibodies to P450IID6 protein in Japanese patients with chronic hepatitis C. J Hepatol. 1997, 26: 992-1000.","journal-title":"J Hepatol"},{"key":"1_CR97","first-page":"613","volume":"21","author":"BD Clifford","year":"1995","unstructured":"Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, Bonkovsky HL: High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology. 1995, 21: 613-619.","journal-title":"Hepatology"},{"key":"1_CR98","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0168-8278(96)80228-5","volume":"25","author":"F Bortolotti","year":"1996","unstructured":"Bortolotti F, Vajro P, Balli F, Giacchino R, Crivellaro C, Barbera C, Cataleta M, Muratori L, Pontisso P, Nebbia G, Zancan L, Bertolini A, Alberti A, Bianchi F: Non-organ specific autoantibodies in children with chronic hepatitis C. J Hepatol. 1996, 25: 614-620.","journal-title":"J Hepatol"},{"key":"1_CR99","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00042737-200201000-00007","volume":"14","author":"GN Dalekos","year":"2002","unstructured":"Dalekos GN, Makri E, Loges S, Obermayer-Straub P, Zachou K, Tsikrikas T, Schimdt E, Papadamou G, Manns MP: Increased incidence of anti-LKM autoantibodies in a consecutive cohort of HCV patients from central Greece. Eur J Gastroenterol Hepatol. 2002, 14: 35-42.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1_CR100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/08916930108994106","volume":"33","author":"H Miyakawa","year":"2000","unstructured":"Miyakawa H, Kitazawa E, Kikuchi K, Fujikawa H, Kawaguchi N, Abe K, Matsushita M, Matsushima H, Igarashi T, Hankins RW, Kako M: Immunoreactivity to various human cytochrome P450 proteins of sera from patients with autoimmune hepatitis, chronic hepatitis B, and chronic hepatitis C. Autoimmunity. 2000, 33: 23-32.","journal-title":"Autoimmunity"},{"key":"1_CR101","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/gut.37.3.406","volume":"37","author":"L Muratori","year":"1995","unstructured":"Muratori L, Lenzi M, Ma Y, Cataleta M, Mieli-Vergani G, Vergani D, Bianchi FB: Heterogeneity of liver\/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease. Gut. 1995, 37: 406-412.","journal-title":"Gut"},{"key":"1_CR102","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2249.1994.tb06585.x","volume":"97","author":"Y Ma","year":"1994","unstructured":"Ma Y, Peakman M, Lobo-Yeo A, Wen L, Lenzi M, Gaken J, Farzaneh F, Mieli-Vergani G, Bianchi FB, Vergani D: Differences in immune recognition of cytochrome P450 2D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection. Clin Exp Immunol. 1994, 97: 94-99.","journal-title":"Clin Exp Immunol"},{"key":"1_CR103","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/0016-5085(93)90657-X","volume":"104","author":"AM Yamamoto","year":"1993","unstructured":"Yamamoto AM, Cresteil D, Homberg JC, Alvarez F: Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative sera. Gastroenterology. 1993, 104: 1762-1767.","journal-title":"Gastroenterology"},{"key":"1_CR104","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0168-8278(99)80092-0","volume":"30","author":"GN Dalekos","year":"1999","unstructured":"Dalekos GN, Wedemeyer H, Obermayer-Straub P, Kayser A, Barut A, Frank H, Manns MP: Epitope mapping of cytochrome P450 2D6 autoantigen in patients with chronic hepatitis C under \u03b1-interferon treatment. J Hepatol. 1999, 30: 366-375.","journal-title":"J Hepatol"},{"key":"1_CR105","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0016-5085(95)90074-8","volume":"108","author":"M Durazzo","year":"1995","unstructured":"Durazzo M, Philipp T, Va Pelt FN, Luttig B, Borghesio E, Michel G, Schmidt E, Loges S, Rizzetto M, Manns MP: Heterogeneity of microsomal autoantibodies (LKM) in chronic hepatitis C and D virus infection. Gastroenterology. 1995, 108: 455-462.","journal-title":"Gastroenterology"},{"key":"1_CR106","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/hep.1840160304","volume":"16","author":"F Lunel","year":"1992","unstructured":"Lunel F, Abuaf N, Frangeul L, Grippon P, Perrin M, Le Coz Y, Valla D, Borotto E, Yamamoto AM, Huraux JM: Liver\/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology. 1992, 16: 630-636.","journal-title":"Hepatology"},{"key":"1_CR107","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/BF02936953","volume":"32","author":"H Miyakawa","year":"1997","unstructured":"Miyakawa H, Kitazawa E, Abe K, Kawaguchi N, Fuzikawa H, Kikuchi K, Kako M, Komatsu T, Hayashi N, Kiyosawa K: Chronic hepatitis C associated with anti-liver\/kidney microsome-1 antibody is not a subgroup of autoimmune hepatitis. J Gastroenterol. 1997, 32: 769-776.","journal-title":"J Gastroenterol"},{"key":"1_CR108","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0168-8278(91)90953-9","volume":"12","author":"M Ruiz-Moreno","year":"1991","unstructured":"Ruiz-Moreno M, Rua MJ, Carreno V, Quironga JA, Manns M, Meyer zum B\u00fcschenfelde K-H: Autoimmune chronic active hepatitis type 2 manifested during interferon therapy in children. J Hepatol. 1991, 12: 265-266.","journal-title":"J Hepatol"},{"key":"1_CR109","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0168-8278(05)80395-2","volume":"21","author":"L Muratori","year":"1994","unstructured":"Muratori L, Lenzi M, Cataleta M, Giostra F, Cassani F, Ballardini G, Zauli D, Bianchi FB: Interferon therapy in liver\/kidney microsomal antibody type 1-positive patients with chronic hepatitis C. J Hepatol. 1994, 21: 199-203.","journal-title":"J Hepatol"},{"key":"1_CR110","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.1840220506","volume":"22","author":"L Todros","year":"1995","unstructured":"Todros L, Saracco G, Durazzo M, Abate ML, Touscoz G, Scaglione L, Verme G, Rizzetto M: Efficacy and safety of interferon alpha therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes. Hepatology. 1995, 22: 1374-1378.","journal-title":"Hepatology"},{"key":"1_CR111","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/hep.1840120120","volume":"12","author":"MP Manns","year":"1990","unstructured":"Manns MP, Jentzsch M, Mergener K: Discordant manifestation of LKM-1 antibody positive autoimmune hepatitis in identical twins [abstract]. Hepatology. 1990, 12: 840-","journal-title":"Hepatology"},{"key":"1_CR112","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/hep.510280502","volume":"28","author":"K Choudhury","year":"1998","unstructured":"Choudhury K, Gregorio GV, Mieli-Vergani G, Vergani D: Immunological cross-reactivity to multiple autoantigens in patients with liver kidney microsomal type 1 autoimmune hepatitis. Hepatology. 1998, 28: 1177-1181.","journal-title":"Hepatology"},{"key":"1_CR113","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/039463200401700112","volume":"17","author":"D-P Bogdanos","year":"2004","unstructured":"Bogdanos D-P, Lenzi M, Okamoto M, Rigopoulou EI, Muratori P, Ma Y, Muratori L, Tsantoulas D, Mieli-Vergani G, Bianchi FB, Vergani D: Multiple viral\/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA 51. Int J Immunopathol Pharmacol. 2004, 17: 83-92.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"1_CR114","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1124\/mol.54.1.8","volume":"54","author":"J Loeper","year":"1998","unstructured":"Loeper J, Louerat-Oriou B, Duport C, Pompon D: Yeast expressed cytochrome P450 2D6 (CYP2D6) exposed on the external face of plasma membrane is functionally competent. Mol Pharmacol. 1998, 54: 8-13.","journal-title":"Mol Pharmacol"},{"key":"1_CR115","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/gut.46.4.553","volume":"46","author":"L Muratori","year":"2000","unstructured":"Muratori L, Parola M, Ripalti A, Robino G, Muratori P, Bellomo G, Carini R, Lenzi M, Landini MP, Albano E, Bianchi FB: Liver\/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. Gut. 2000, 46: 553-561.","journal-title":"Gut"},{"key":"1_CR116","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/hep.510240619","volume":"24","author":"HF Lohr","year":"1996","unstructured":"Lohr HF, Schlaak JF, Lohse AW, Bocher WO, Arenz M, Gerken G, Meyer Zum Buschenfelde KH: Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis. Hepatology. 1996, 24: 1416-1421.","journal-title":"Hepatology"},{"key":"1_CR117","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-0676.2001.210103.x","volume":"21","author":"M Arenz","year":"2001","unstructured":"Arenz M, Pingel S, Schirmacher P, Meyer zum Buschenfelde KH, Lohr HF: T cell receptor Vbeta chain restriction and preferred CDR3 motifs of liver-kidney microsomal antigen (LKM-1)-reactive T cells from autoimmune hepatitis patients. Liver. 2001, 21: 18-25.","journal-title":"Liver"},{"key":"1_CR118","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4049\/jimmunol.169.1.277","volume":"169","author":"Y Ma","year":"2002","unstructured":"Ma Y, Thomas MG, Okamoto M, Bogdanos DP, Nagl S, Kerkar N, Lopes AR, Muratori L, Lenzi M, Bianchi FB, Mieli-Vergani G, Vergani D: Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule. J Immunol. 2002, 169: 277-285.","journal-title":"J Immunol"},{"key":"1_CR119","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0016-5085(96)70020-3","volume":"111","author":"CP Strassburg","year":"1996","unstructured":"Strassburg CP, Obermayer-Straub P, Alex B, Durazzo M, Rizzetto M, Tukey RH, Manns MP: Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis. Gastroenterology. 1996, 111: 1582-1592.","journal-title":"Gastroenterology"},{"key":"1_CR120","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(94)91966-6","volume":"344","author":"T Philipp","year":"1994","unstructured":"Philipp T, Durazzo M, Trautwein C, Alex B, Straub P, Lamb JG, Johnson EF, Tukey RH, Manns MP: LKM-3 autoantibodies in chronic hepatitis D recognize the UDP-glucuronosyl-transferases. Lancet. 1994, 344: 578-581.","journal-title":"Lancet"},{"key":"1_CR121","first-page":"232","volume":"54","author":"O Crivelli","year":"1983","unstructured":"Crivelli O, Lavarini C, Chiaberge E, Amoroso A, Farci P, Negro F, Rizzetto M: Microsomal autoantibodies in chronic infection with HBsAg associated delta (d) agent. Clin Exp Immunol. 1983, 54: 232-238.","journal-title":"Clin Exp Immunol"},{"key":"1_CR122","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1572-0241.2001.03383.x","volume":"96","author":"A Csepregi","year":"2001","unstructured":"Csepregi A, Nemesanszky E, Luettig B, Obermayer-Starub P, Manns MP: LKM3 autoantibodies in hepatitis C cirrhosis: a further phenomenon of the HCV-induced autoimmunity. Am J Gastroenterol. 2001, 96: 910-911.","journal-title":"Am J Gastroenterol"},{"key":"1_CR123","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1053\/jhep.2001.24101","volume":"33","author":"T Bachrich","year":"2001","unstructured":"Bachrich T, Thalhammer T, Jager W, Haslmayer P, Alihodzic B, Bakos S, Hitchman E, Senderowicz AM, Penner E: Characterization of autoantibodies against uridine-diphospate glucuronosyltransferase in patients with inflammatory liver diseases. Hepatology. 2001, 33: 1053-1059.","journal-title":"Hepatology"},{"key":"1_CR124","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hep.1840160407","volume":"16","author":"N Abuaf","year":"1992","unstructured":"Abuaf N, Johanet C, Chretien P, Martini E, Soulier E, Laperche S, Homberg JC: Characterization of liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis. Hepatology. 1992, 16: 892-898.","journal-title":"Hepatology"},{"key":"1_CR125","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.36.5.749","volume":"36","author":"M Lenzi","year":"1995","unstructured":"Lenzi M, Manotti P, Muratori L, Cataleta M, Ballardini G, Cassani F, Bianchi FB: Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection. Gut. 1995, 36: 749-754.","journal-title":"Gut"},{"key":"1_CR126","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0022-1759(95)00192-X","volume":"187","author":"L Muratori","year":"1995","unstructured":"Muratori L, Cataleta M, Muratori P, Manotti P, Lenzi M, Cassani F, Bianchi FB: Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: comparison of three different techniques. J Immunol Methods. 1995, 187: 259-264.","journal-title":"J Immunol Methods"},{"key":"1_CR127","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0016-5085(99)70186-1","volume":"116","author":"P Lapierre","year":"1999","unstructured":"Lapierre P, Hajoui O, Homberg J-C, Alvarez F: Formininotransferase cyclodeaminase is organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis. Gastroenterology. 1999, 116: 643-649.","journal-title":"Gastroenterology"},{"key":"1_CR128","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1365-2249.1998.00754.x","volume":"114","author":"N Pelli","year":"1998","unstructured":"Pelli N, Fensom AH, Slade C, Boa F, Mieli-Vergani G, Vergani D: Argininosuccinate lyase: a new autoantigen in liver disease. Clin Exp Immunol. 1998, 114: 455-461.","journal-title":"Clin Exp Immunol"},{"key":"1_CR129","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1006\/jaut.2000.0488","volume":"16","author":"P Obermayer-Straub","year":"2001","unstructured":"Obermayer-Straub P, Manns MP: Hepatitis C and D, retroviruses and autoimmune manifestations. J Autoimmunity. 2001, 16: 275-285.","journal-title":"J Autoimmunity"},{"key":"1_CR130","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/gut.42.5.721","volume":"42","author":"L Muratori","year":"1998","unstructured":"Muratori L, Cataleta M, Muratori P, Lenzi M, Bianchi FB: Liver\/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis. Gut. 1998, 42: 721-726.","journal-title":"Gut"},{"key":"1_CR131","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/hmg\/8.2.277","volume":"8","author":"C Rinderle","year":"1999","unstructured":"Rinderle C, Christensen HM, Schweiger S, Lehrach H, Yaspo ML: AIRE encodes a nuclear protein co-localizing with cytoskeletal filaments: altered sub-cellular distribution of mutants lacking the PHD zinc fingers. Hum Mol Genet. 1999, 8: 277-290.","journal-title":"Hum Mol Genet"},{"key":"1_CR132","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1053\/jhep.2001.24031","volume":"33","author":"A Vogel","year":"2001","unstructured":"Vogel A, Liermann H, Harms A, Strassburg CP, Manns MP, Obermayer-Straub P: Autoimmune regulator AIRE: evidence for genetic differences between autoimmune hepatitis and hepatitis as part of the autoimmune polyglandular syndrome type 1. Hepatology. 2001, 33: 1047-1052.","journal-title":"Hepatology"},{"key":"1_CR133","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0014-5793(97)00797-7","volume":"412","author":"G Gebre-Medhin","year":"1997","unstructured":"Gebre-Medhin G, Husebye ES, Gustafsson J, Winqvist O, Goksoyr A, Rorsman F, Kampe O: Cytochrome P450IA2 and aromatic L-amino acid decarboxylase are hepatic autoantigens in autoimmune polyendocrine syndrome type I. FEBS Letters. 1997, 412: 439-445.","journal-title":"FEBS Letters"},{"key":"1_CR134","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0168-8278(03)00356-8","volume":"39","author":"GN Dalekos","year":"2003","unstructured":"Dalekos GN, Obermayer-Straub P, Bartels M, Maeda T, Kayser A, Braun S, Loges S, Schmidt E, Gershwin ME, Manns MP: Cytochrome P450 2A6: A new hepatic autoantigen in patients with chronic hepatitis C virus infection. J Hepatol. 2003, 39: 800-806.","journal-title":"J Hepatol"},{"key":"1_CR135","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1172\/JCI114660","volume":"85","author":"M Bourdi","year":"1990","unstructured":"Bourdi M, Larrey D, Nataf J, Bernuau J, Pessayre D, Iwasaki M, Guengerich FP, Beaune PH: Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P450 IA2: A specific marker of dihydralazine-induced hepatitis. J Clin Invest. 1990, 85: 1967-1973.","journal-title":"J Clin Invest"},{"key":"1_CR136","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1054-3589(08)60175-1","volume":"30","author":"PH Beaune","year":"1994","unstructured":"Beaune PH, Pessayre D, Dansette P, Mansuy D, Manns MP: Autoantibodies against cytochromes P450: Role in human diseases. Adv Pharmacol. 1994, 30: 199-245.","journal-title":"Adv Pharmacol"},{"key":"1_CR137","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1210\/jcem-64-3-494","volume":"64","author":"P Ahonen","year":"1987","unstructured":"Ahonen P, Miettinen A, Perheentupa J: Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure. J Clin Endocrinol Metabol. 1987, 64: 494-500.","journal-title":"J Clin Endocrinol Metabol"},{"key":"1_CR138","doi-asserted-by":"crossref","first-page":"8626","DOI":"10.1073\/pnas.92.19.8626","volume":"92","author":"F Rorsman","year":"1995","unstructured":"Rorsman F, Husebye ES, Winquist O, Bj\u00f6rk E, Karlsson FA, K\u00e4mpe O: Aromatic-L-aminoacid decarboxylase, a pyridoxal phosphate-dependent enzyme, is a beta-cell autoantigen. Proc Natl Acad Sci USA. 1995, 92: 8626-8629.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR139","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0168-8278(03)00387-8","volume":"39","author":"D Kyriakou","year":"2003","unstructured":"Kyriakou D, Alexandrakis M, Zachou K, Passam F, Stathakis N, Dalekos GN: Hemopoietic progenitor cells and bone marrow stromal cells in patients with autoimmune hepatitis type 1 and primary biliary cirrhosis. J Hepatol. 2003, 39: 679-685.","journal-title":"J Hepatol"},{"key":"1_CR140","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1053\/he.2000.5980","volume":"31","author":"AJ Czaja","year":"2000","unstructured":"Czaja AJ, Manns MP, McFarlane IG, Hoofnagle JH: Autoimmune hepatitis: The investigational and clinical challenges. Hepatology. 2000, 31: 1194-2000.","journal-title":"Hepatology"},{"key":"1_CR141","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/j.1572-0241.2001.03707.x","volume":"96","author":"AJ Czaja","year":"2001","unstructured":"Czaja AJ: Understanding the pathogenesis of autoimmune hepatitis. Am J Gastroenterol. 2001, 96: 1224-1231.","journal-title":"Am J Gastroenterol"}],"container-title":["Journal of Autoimmune Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1740-2557-1-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:33:38Z","timestamp":1728304418000},"score":1,"resource":{"primary":{"URL":"https:\/\/jautoimdis.biomedcentral.com\/articles\/10.1186\/1740-2557-1-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,15]]},"references-count":141,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,12]]}},"alternative-id":["1"],"URL":"https:\/\/doi.org\/10.1186\/1740-2557-1-2","relation":{},"ISSN":["1740-2557"],"issn-type":[{"value":"1740-2557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10,15]]},"assertion":[{"value":"14 December 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"2"}}